This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

BeesFree Enters Consulting Agreement With Chief Scientist, Dr. Francesca Del Vecchio

WEST PALM BEACH, Fla., Nov. 8, 2012 /PRNewswire/ --  BeesFree, Inc. (OTC QB: BEES), the worldwide distributor of BeesVita Plus™ and the Beespenser™, announced today that it has entered into a consulting agreement with Dr. Francesca del Vecchio, the Company's Chief Scientist.  Dr. del Vecchio will continue in her current capacity through October 31, 2015. Dr. del Vecchio is the inventor of both BeesVita Plus™, an innovative composite food supplement for honey bees that works to prevent the effects of Colony Collapse Disorder (CCD), and the Beespenser™, an automated external honey bee feeding system.

Dr. del Vecchio possesses more than 18 years of professional research experience in a variety of academic, corporate and private research and development centers.  She has managed projects in the fields of biology, chemistry, botany and biochemistry.  Her specialty is in the development of advanced techniques for the formulation and preparation of biochemical compounds and DNA sequencing, e.g. DNA library construction, ligation in plasmid cloning vectors and analysis of genomic DNA sequencing results.  Dr. del Vecchio has a Ph.D. in biochemistry from Cambridge University, United Kingdom and a University Degree in Biology from the University of 'La Sapienza' in Rome, Italy.

"We are excited to have someone as talented and knowledgeable as Dr. del Vecchio committed to the company for another three years," stated Mr. David Todhunter, CEO and President of BeesFree, Inc.  "Her knowledge of honey bees both from a scientific perspective and as a beekeeper will help keep our products on the cutting edge.  We believe that her experience and key industry relationships will continue to present the company with opportunities for market expansion."

"I am very happy to be part of a company so dedicated to the health and welfare of honey bees worldwide," stated Dr. del Vecchio.  "I'm looking forward to the challenge of keeping our products at the forefront of technology."

About BeesFree, Inc.   BeesFree, Inc. (OTC QB: BEES), a company focused on developing innovative solutions for the global beekeeping community, owns a patent pending nutritional food supplement that helps honey bees avoid the effects of Colony Collapse Disorder (CCD) and a patent pending automated honey bee feeding system.  Visit www.beesfree.biz to learn more about why the bees are disappearing, and how beekeepers can combat the honey bee decline.

Forward-Looking Statements   Statements about the future expectations of BeesFree, Inc. and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as that term is defined in the Private Securities Litigation Reform Act of 1995. BeesFree, Inc. intends that such forward-looking statements shall be subject to the safe harbors created thereby. Since these statements involve certain risks and uncertainties and are subject to change at any time, BeesFree Inc.'s actual results could differ materially from expected results.

Contact    Investor Relations Contact:TPW Capital, Inc. Thomas Walsh, PresidentTelephone: (201) 424-4573Email: Marketing@beesfree.biz

SOURCE BeesFree, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs